Population Health Efforts Track Where the Money Goes
Anthem-Cigna Merger Blocked; Judge Cites Anticompetitive Effects
Hopkins' Researchers Discover Carcinogenic Metals in E-Cigarette Liquid
Michigan Study Finds Obesity Lowers Hospice Use Among Seniors
Breast Cancer Patients Not Getting Desired Genetic Testing, Counseling
Gastric Bypass Reversal: Diabetes Can Return, Even if Weight Doesn't
Parity Law Boosted Access to Mental Health Services for Kids With Autism
What We're Reading: Right to Try Support; Ryan on ACA Replacement; and Vaccine Safety
Implementing Alternative Payment Models: Just Do It, Advocate Panelists at AcademyHealth
Data Shortfalls Hamper Medicaid's Oversight Ability, GAO Finds
PMC Report Proposes Strategies for Clinical Integration of Personalized Medicine
Pivotal Trials Launch for 4 NIH-Funded Artificial Pancreas Projects
Low-Income Women Less Likely to Keep Jobs After Breast Cancer Treatment
What We're Reading: Rx Spending Slowed; a HDHP Experiment; and Calif. Responds to Zika
Encouraging Results for New Strategy to Treat Juvenile Batten Disease
Population-Level Weight Maintenance Programs Could Help Prevent Diabetes, Study Finds
ACS Study Voices Concerns Over Low US Lung Cancer Screening Rates
What We're Reading: ACA Sign-ups Fall Short; Opposition to Block Grants; and Drug Coupons
Progress in Population Health Slow, With Doctors Still Resisting Change, Report Finds
ICER's Updated Value Framework Open for Public Comment
Early Discharge From the ED Results in 10,000 Annual Deaths for Medicare Patients
FOURIER Study Finds Repatha Reduces Risk of Cardiovascular Events
COPD More Prevalent in Adults Whose Parents Had the Disease
Diabetes More Common Among HIV Patients, Study Finds
5 Key Highlights From the AcademyHealth National Health Policy Conference
This Week in Managed Care: February 3, 2017
What We're Reading: GOP Weighs Fixing ACA, Covering Illegal Immigrants, and Vulnerable Patients
AJMC® in the Press, February 3, 2017
Reports Highlight Special Needs Children as Congress Weighs Medicaid Changes
Merck, Pfizer Publish Results for Ertugliflozin as Monotherapy in Type 2 Diabetes